RAPT Therapeutics’ stock plunges as FDA halts two clinical trials
RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its experimental inflammation drug.
The average monthly payment on used electric vehicles, which are now cheaper than hybrids and gas-engine cars, are approaching affordable...
Investors are facing the busiest quarterly rebalancing in about four years on Friday in a shakeup that could impact roughly...
With Medicare prescription-drug benefits on the brink of a shake-up, enrollees who hope to minimize their costs at the pharmacy...
Trump Media & Technology Group Corp.’s stock dropped to its lowest level since it went public in March Friday, as...
Immigration will have an effect on your retirement — but it’s probably not what you think.
New York State may approach $1 billion in legal pot sales this year as its legal cannabis business gains traction...